Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit Medical Dialogues Bureau13 Aug 2019 9:15 AM ISTThe ruling came in the appeals of U.S. District Court decisions in the cases of Eli Lilly and Company v. Dr Reddy's Laboratories and Eli Lilly and...
Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu Medical Dialogues Bureau20 July 2019 11:37 AM ISTIn a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm Medical Dialogues Bureau10 July 2019 10:04 AM ISTThe Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months...
Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 1:32 PM ISTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
Dr Reddys launches generic version of Tobi in US market Farhat Nasim26 Jun 2019 3:07 PM ISTThe product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 11:09 AM ISTHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx Farhat Nasim15 Jun 2019 10:00 AM ISTDr Reddy's (Dr Reddys) Labs said Tosymra and Zembrace were designed and developed with the goal of addressing unmet needs of large but discrete...
Dr Reddys yields positive results from phase 2b study of new psoriasis drug Farhat Nasim10 Jun 2019 2:02 PM ISTThe detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 11:00 AM ISTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
Sun pharma, Dr Reddys, others deny allegations of price fixing in US Garima16 May 2019 9:35 AM ISTIn separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit Farhat Nasim14 May 2019 4:57 PM ISTMumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
Dr Reddy's expands injectable portfolio with acquisition of 42 ANDAs in US Farhat Nasim15 April 2019 10:00 AM ISTThis transaction will help augment Dr Reddy's Labs injectables product portfolio in the U.S. market and globally.Hyderabad: Dr Reddy's Laboratories...
